Olema Pharmaceuticals, Inc. (OLMA)
OLMA Stock Price Chart
Explore Olema Pharmaceuticals, Inc. interactive price chart. Choose custom timeframes to analyze OLMA price movements and trends.
OLMA Company Profile
Discover essential business fundamentals and corporate details for Olema Pharmaceuticals, Inc. (OLMA) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
19 Nov 2020
Employees
96.00
Website
https://www.olema.comCEO
Sean P. Bohen
Description
Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of recurrent, locally advanced, or metastatic estrogen receptor-positive, human epidermal growth factor receptor 2-negative breast cancer. The company was formerly known as CombiThera, Inc. and changed its name to Olema Pharmaceuticals, Inc. in March 2009. Olema Pharmaceuticals, Inc. was incorporated in 2006 and is headquartered in San Francisco, California.
OLMA Financial Timeline
Browse a chronological timeline of Olema Pharmaceuticals, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 11 May 2026
Upcoming earnings on 11 Nov 2025
EPS estimate is -$0.44.
Earnings released on 11 Aug 2025
EPS came in at -$0.51 falling short of the estimated -$0.43 by -18.60%.
Earnings released on 13 May 2025
EPS came in at -$0.36 surpassing the estimated -$0.49 by +26.53%.
Earnings released on 18 Mar 2025
EPS came in at -$0.51 surpassing the estimated -$0.63 by +19.05%.
Earnings released on 12 Nov 2024
EPS came in at -$0.60 falling short of the estimated -$0.59 by -1.69%.
Earnings released on 6 Aug 2024
EPS came in at -$0.54 matching the estimated -$0.54.
Earnings released on 8 May 2024
EPS came in at -$0.56 falling short of the estimated -$0.53 by -5.66%.
Earnings released on 11 Mar 2024
EPS came in at -$0.49 matching the estimated -$0.49, while revenue for the quarter reached $1.88M .
Earnings released on 7 Nov 2023
EPS came in at -$0.48 surpassing the estimated -$0.51 by +5.88%.
Earnings released on 8 Aug 2023
EPS came in at -$0.49 surpassing the estimated -$0.73 by +32.88%.
Earnings released on 9 May 2023
EPS came in at -$0.70 falling short of the estimated -$0.66 by -6.06%.
Earnings released on 9 Mar 2023
EPS came in at -$0.65 matching the estimated -$0.65.
Earnings released on 8 Nov 2022
EPS came in at -$0.57 surpassing the estimated -$0.79 by +27.85%.
Earnings released on 9 Aug 2022
EPS came in at -$0.82 falling short of the estimated -$0.65 by -26.15%.
Earnings released on 9 May 2022
EPS came in at -$0.58 falling short of the estimated -$0.57 by -1.75%.
Earnings released on 28 Feb 2022
EPS came in at -$0.54 falling short of the estimated -$0.51 by -5.88%.
Earnings released on 10 Nov 2021
EPS came in at -$0.45 surpassing the estimated -$0.47 by +4.26%.
Earnings released on 10 Aug 2021
EPS came in at -$0.42 falling short of the estimated -$0.39 by -7.69%.
Earnings released on 11 May 2021
EPS came in at -$0.39 falling short of the estimated -$0.28 by -39.29%.
Earnings released on 17 Mar 2021
EPS came in at -$0.50 falling short of the estimated -$0.18 by -177.78%.
Earnings released on 19 Nov 2020
EPS came in at -$0.17 .
Earnings released on 30 Sept 2020
EPS came in at -$0.21 .
OLMA Stock Performance
Access detailed OLMA performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.